Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

ClinicalTrials.gov ID: NCT00082511

Public ClinicalTrials.gov record NCT00082511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment With GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Open label safety and efficacy follow-up.

Study identification

NCT ID
NCT00082511
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genelabs Technologies
Industry
Enrollment
114 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2003
Primary completion
Jul 31, 2005
Completion
Jul 31, 2005
Last update posted
Jan 13, 2008

2003 – 2005

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
Wallace Rheumatic Study Center Los Angeles California 90048
Lifestyles Health Science Center Rancho Mirage California 92270
University of California San Diego San Diego California 92093-0943
East Bay Rheumatology Group San Leandro California 94578
Center for Rheumatology, Immunology and Arthritis Fort Lauderdale Florida 33334
Rheumatology Associates of Central Florida Orlando Florida 32806-6264
Tampa Medical Group, P.A. Tampa Florida 33614
Northwestern University Chicago Illinois 60611
Johns Hopkins University Baltimore Maryland 21205
St. John's Medical Research Group Springfield Missouri 65804
Washington University School of Medicine St Louis Missouri 63110
SUNY Downstate Medical Center Brooklyn New York 11203
North Shore University Hospital, Division of Rheumatology Manhasset New York 11030
Albert Einstein Medical School The Bronx New York 10461
Oklahoma Center for Arthritis Therapy Tulsa Oklahoma 74114
Oregon Health & Science University Portland Oregon 97201
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
University of Pittsburgh Pittsburgh Pennsylvania 15261
Sentara Medical Group DBA Virginia Beach Virginia 23462
Seattle Rheumatology Associates Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00082511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2008 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00082511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →